PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine.
CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression.
A more detailed understanding of patient endotypes will support drug development by identifying new targets in specific patient groups, reducing clinical trial sizes and costs, and increasing success rates, ultimately improving outcomes for patients.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Maia Building (B270), Babraham Research Campus,united Kingdom
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.plaquetec.com
- Keywords
- Constructive Bio.
- HQ
- Cambridge
Plaquetec Ltd. Questions
Plaquetec Ltd.'s website is http://www.plaquetec.com
Plaquetec Ltd.'s LinkedIn profile is https://uk.linkedin.com/company/plaquetec-ltd
Plaquetec Ltd. has
4 employees.
View email and phone details for 4
employees at Plaquetec Ltd..
Plaquetec Ltd.'s industry is
Medical Equipment Manufacturing
Plaquetec Ltd.'s top competitors are
Charm Therapeutics,
Linkgevity,
Rxcelerate,
Storm Therapeutics Limited,
Shift Bioscience,
Loqus23 Therapeutics Ltd,
Cardiatec Bio,
Constructive Bio,
Babraham Research Campus,
Xap Therapeutics.
Plaquetec Ltd.'s categories are Medical Equipment Manufacturing
Plaquetec Ltd.'s founding year is 2008
